Charvát J, Linke Z, Horáèková M, Prausová J
Medical Department of 2nd Faculty of Medicine of Charles University and the Motol Faculty Hospital, Prague, Czech Republic.
Support Care Cancer. 2006 Nov;14(11):1162-5. doi: 10.1007/s00520-006-0073-2. Epub 2006 Apr 5.
Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients.
One hundred one totally implantable venous ports were placed in 100 patients with malignancies from January 1, 2003 until March 31, 2005. Catheter of venous port was preferably inserted via the right internal jugular vein. We recorded a number of successful implantations using this venous approach and the rate of complications during the procedure and follow-up.
Ninety-seven catheters (96%) of totally implantable venous ports were inserted via the right internal jugular vein in 96 patients, and only in four cases were we not able to access this vein. We had no complications related to catheter insertion via the right internal jugular vein. Follow-up was made in all 96 patients with a total access days of 41 in 151 days (mean: 407 days). Premature catheter removal was required in six (6.2%, 0.144 per 1,000 access days) due to complications: three catheter dislocations/malfunctions (3.1%, 0.072 per 1,000 access days), one port-related sepsis, one pocket port infection, and one decubitus over port (1%, 0.024 per 1,000 access days). Six venous ports were removed after completion of the treatment at the patient's request.
The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
评估经右颈内静脉插入导管进行静脉港植入术在肿瘤患者中的适用性和安全性。
2003年1月1日至2005年3月31日期间,为100例恶性肿瘤患者植入了101个完全植入式静脉港。静脉港导管优先经右颈内静脉插入。我们记录了采用这种静脉入路的成功植入数量以及手术过程中和随访期间的并发症发生率。
96例患者经右颈内静脉插入了97根(96%)完全植入式静脉港的导管,仅4例无法进入该静脉。我们没有与经右颈内静脉插入导管相关的并发症。对所有96例患者进行了随访,在151天内总使用天数为41天(平均:407天)。由于并发症,6例(6.2%,每1000个使用日0.144例)需要提前拔除导管:3例导管移位/故障(3.1%,每1000个使用日0.072例),1例与端口相关的败血症,1例端口袋感染,1例端口处褥疮(1%;每1000个使用日0.024例)。6个静脉港在患者要求完成治疗后被拔除。
经右颈内静脉插入导管植入完全植入式静脉港成功率高,且无任何早期并发症。随访还显示,需要拔除端口的晚期并发症发生率较低。